Marimastat
In Stock•Starting at $46 for 1 mg•Purity ≥ 98%
| CAS No. | 154039-60-8 |
|---|---|
| MDL No. | MFCD00866242 |
| MF | C15H29N3O5 |
| MW | 331.41 |
| InChI Key | OCSMOTCMPXTDND-OUAUKWLOSA-N |
Pricing & Availability
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| 1 mg | 98% | $46 | In Stock | |
| 5 mg | 98% | $55 | In Stock | |
| 25 mg | 98% | $177 | In Stock | |
| 50 mg | 98% | $262 | In Stock | |
| 100 mg | 98% | $418 | In Stock |
Product Information
Marimastat is a secondary carboxamide formed by the formal condensation of the carboxy group of (2R)-2-[(1S)-1-hydroxy-2-(hydroxyamino)-2-oxoethyl]-4-methylpentanoic acid with the alpha-amino group of N,3-dimethyl-L-valinamide. It functions as an antineoplastic agent and matrix metalloproteinase inhibitor, and is classified as a secondary carboxamide and hydroxamic acid.
| CAS No. | 154039-60-8 |
|---|---|
| Product Name | Marimastat |
Biological Targets
MMP12·MMP3·MMP7·MMP9·MMP1·
Associated Conditions
breast cancer·lung cancer
* The information provided here is compiled from public sources and is for reference only.